Cells lacking IKKα show nuclear cyclin D1 overexpression and a neoplastic phenotype: Role of IKKα as a tumor suppressor

Molecular Cancer Research

Volumn 9, Issue 3, 2011, Pages 341-349

  Kwak, Youn Tae ^a   Radaideh, Sofyan M ^a   Ding, Lianghao ^a   Li, Rui ^a   Frenkel, Eugene ^a   Story, Michael D ^a,b   Girard, Luc ^a   Minna, John ^a   Verma, Udit N ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; CYCLIN D1; I KAPPA B ALPHA; RNA;

ANIMAL CELL; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CARCINOGENESIS; CELL ANCHORAGE; CELL GROWTH; CELL PROLIFERATION; CLONOGENESIS; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; LUNG CANCER; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; APOPTOSIS; CARCINOGENICITY TESTS; CELL LINE; CELL NUCLEUS; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CYCLIN D1; GENES, TUMOR SUPPRESSOR; HUMANS; I-KAPPA B KINASE; MICE; MICROARRAY ANALYSIS; PHENOTYPE; PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANSPLANTATION, HETEROLOGOUS;

MUS MUSCULUS;

EID: 79952855952     PISSN: 15417786     EISSN: 15573125     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-10-0248     Document Type: Article

References (50)

1. Basseres DS, Baldwin AS. Nuclear factor-kappaB and inhibitor of kappaB kinase pathways in oncogenic initiation and progression. Oncogene 2006;25:6817-30. (Pubitemid 44657854)
2. Karin M, Cao Y, Greten FR, Li ZW. NF-kappaB in cancer: from innocent bystander to major culprit. Nat Rev Cancer 2002;2:301-10. (Pubitemid 37328783)
3. DiDonato JA, Hayakawa M, Rothwarf DM, Zandi E, Karin M. A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB. Nature 1997;388:548-54. (Pubitemid 27339997)
4. Mercurio F, Zhu H, Murray BW, Shevchenko A, Bennett BL, Li J, et al. IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation. Science 1997;278:860-6. (Pubitemid 27467923)
5. Woronicz JD, Gao X, Cao Z, Rothe M, Goeddel DV. IkappaB kinase-beta: NF-kappaB activation and complex formation with IkappaB kinase-alpha and NIK. Science 1997;278:866-9. (Pubitemid 27467924)
6. Zandi E, Rothwarf DM, Delhase M, Hayakawa M, Karin M. The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation. Cell 1997;91:243-52. (Pubitemid 27456391)
7. Rothwarf DM, Zandi E, Natoli G, Karin M. IKK-gamma is an essential regulatory subunit of the IkappaB kinase complex. Nature 1998;395:297-300. (Pubitemid 28447557)
8. Yamaoka S, Courtois G, Bessia C, Whiteside ST, Weil R, Agou F, et al. ComplementationcloningofNEMO,acomponentof theI[kappa]Bkinase complex essential for NF-[kappa]B activation. Cell 1998;93:1231-40. (Pubitemid 28307427)
9. Zandi E, Chen Y, Karin M. Direct phosphorylation of IkappaB by IKKalpha and IKKbeta: discrimination between free and NF-kappaB-bound substrate. Science 1998;281:1360-3. (Pubitemid 28406830)
10. Kwak YT, Guo J, Shen J, Gaynor RB. Analysis of domains in the IKKalpha and IKKbeta proteins that regulate their kinase activity. J Biol Chem 2000;275:14752-9. (Pubitemid 30339769)
11. Senftleben U, Cao Y, Xiao G, Greten FR, Krahn G, Bonizzi G, et al. Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway. Science 2001;293:1495-9. (Pubitemid 32801552)
12. Yamamoto Y, Verma UN, Prajapati S, Kwak YT, Gaynor RB. A nucleosomal role of IKKa in histone H3 phosphorylation is critical for cytokine-induced activation of NF-kB regulated genes. Nature 2003;423:655-9.
13. Kwak YT, Li R, Becerra CR, Tripathy D, Frenkel EP, Verma UN. IkappaB kinase alpha regulates subcellular distribution and turnover of cyclin D1 by phosphorylation. J Biol Chem 2005;280:33945-52. (Pubitemid 41443114)
14. Hu Y, Baud V, Delhase M, Zhang P, Deerinck T, Ellisman M, et al. Abnormal morphogenesis but intact IKK activation in mice lacking the IKKalpha subunit of IkappaB kinase. Science 1999;284:316-20.
15. Li Q, Lu Q, Hwang JY, Buscher D, Lee KF, Izpisua-Belmonte JC, et al. IKK1-deficient mice exhibit abnormal development of skin and skeleton. Genes Dev 1999;13:1322-8. (Pubitemid 29250199)
16. Tanaka M, Fuentes ME, Yamaguchi K, Durnin MH, Dalrymple SA, Hardy KL, et al. Embryonic lethality, liver degeneration, and impaired NF-kappa B activation in IKK-beta-deficient mice. Immunity 1999;10:421-9. (Pubitemid 29205478)
17. Hu Y, Baud V, Oga T, Kim KI, Yoshida K, Karin M. IKKalpha controls formation of the epidermis independently of NF-kappaB. Nature 2001;410:710-4. (Pubitemid 32290360)
18. Sil AK, Maeda S, Sano Y, Roop DR, Karin M. IkappaB kinase-alpha acts in the epidermis to control skeletal and craniofacial morphogenesis. Nature 2004;428:660-4. (Pubitemid 38524809)
19. Betticher DC, Thatcher N, Altermatt HJ, Hoban P, Ryder WD, Heigh-way J. J. Alternate splicing produces a novel cyclin D1 transcript. Oncogene 1995;11:1005-11.
20. Hibberts NA, Simpson DJ, Bicknell JE, Broome JC, Hoban PR, Clayton RN, et al. Analysis of cyclin D1 (CCND1) allelic imbalance and overexpression in sporadic human pituitary tumors. Clin Cancer Res 1999;5:2133-9. (Pubitemid 29399269)
21. Bani-Hani K, Martin IG, Hardie LJ, Mapstone N, Briggs JA, Forman D, et al. Prospective study of cyclin D1 overexpression in Barrett's esophagus: association with increased risk of adenocarcinoma. J Natl Cancer Inst 2000;92:1316-21. (Pubitemid 30660591)
22. Diehl JA. Cycling to cancer with cyclin D1. Cancer Biol Ther 2002;1:226-31.
23. Chen CH, Shen J, Lee WJ, Chow SN. Overexpression of cyclin D1 and c-Myc gene products in human primary epithelial ovarian cancer. Int J Gynecol Cancer 2005;15:878-83. (Pubitemid 41783096)
24. Weroha SJ, Li SA, Tawfik O, Li JJ. Overexpression of cyclins D1 and D3 during estrogen-induced breast oncogenesis in female ACI rats. Carcinogenesis 2006;27:491-8. (Pubitemid 43372878)
25. Diehl JA, Zindy F, Sherr CJ. Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway. Genes Dev 1997;11:957-72. (Pubitemid 27199876)
26. Diehl JA, Cheng M, Roussel MF, Sherr CJ. Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization. Genes Dev 1998;12:3499-511. (Pubitemid 28553242)
27. Solomon DA, Wang Y, Fox SR, Lambeck TC, Giesting S, Lan Z, et al. Cyclin D1 splice variants. Differential effects on localization, RB phosphorylation, and cellular transformation. J Biol Chem 2003;278:30339-47. (Pubitemid 36962428)
28. Lu F, Gladden AB, Diehl JA. An alternatively spliced cyclin D1 isoform, cyclin D1b, is a nuclear oncogene. Cancer Res 2003;63:7056-61. (Pubitemid 37413439)
29. Verma UN, Yamamoto Y, Prajapati S, Gaynor RB. Nuclear role of I kappa B Kinase-gamma/NF-kappa B essential modulator (IKK gamma/NEMO) in NF-kappa B-dependent gene expression. J Biol Chem 2004;279:3509-15. (Pubitemid 38140590)
30. Smyth GK. Linear models and empirical bayes methods for assessing differential expression inmicroarray experiments. Stat Appl Genet Mol Biol 2004;3:article 3.
31. Alt JR, Cleveland JL, Hannink M, Diehl JA. Phosphorylation-dependent regulation of cyclin D1 nuclear export and cyclin D1-dependent cellular transformation. Genes Dev 2000;14:3102-14. (Pubitemid 32015129)
32. Gladden AB, Woolery R, Aggarwal P, Wasik MA, Diehl JA. Expression of constitutively nuclear cyclin D1 in murine lymphocytes induces Bcell lymphoma. Oncogene 2006;25:998-1007. (Pubitemid 43277008)
33. Linzer DI, Nathans D. Nucleotide sequence of a growth-related mRNA encoding a member of the prolactin-growth hormone family. Proc Natl Acad Sci U S A 1984;81:4255-9. (Pubitemid 14052422)
34. Connor AM, Waterhouse P, Khokha R, Denhardt DT. Characterization of a mouse mitogen-regulated protein/proliferin gene and its promoter: a member of the growth hormone/prolactin gene superfamily. Biochim Biophys Acta 1989;1009:75-82. (Pubitemid 19218397)
35. Bonaldo MF, Lennon G, Soares MB. Normalization and subtraction: two approaches to facilitate gene discovery. Genome Res 1996;6:791-806. (Pubitemid 26385362)
36. Rothe M, Pan MG, Henzel WJ, Ayres TM, Goeddel DV. The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins. Cell 1995;83:1243-52. (Pubitemid 26007814)
37. Wilkinson MF, Kleeman J, Richards J, MacLeod CL. A novel oncofetal gene is expressed in a stage-specific manner in murine embryonic development. Dev Biol 1990;141:451-5.
38. Nagira M, Imai T, Ishikawa I, Uwabe KI, Yoshie O. Mouse homologue of C33 antigen (CD82), a member of the transmembrane 4 superfamily: complementary DNA, genomic structure, and expression. Cell Immunol 1994;157:144-57. (Pubitemid 24259460)
39. Stewart C, Parente F, Piehl F, Farnebo F, Quincey D, Silins G, et al. Characterization of the mouse Men1 gene and its expression during development. Oncogene 1998;17:2485-93. (Pubitemid 28544718)
40. Tashiro K, Tada H, Heilker R, Shirozu M, Nakano T, Honjo T. Signal sequence trap: a cloning strategy for secreted proteins and type I membrane proteins. Science 1993;261:600-3. (Pubitemid 23278369)
41. Tamura RN, Cooper HM, Collo G, Quaranta V. Proc Natl Acad Sci U S A 1991;88:10183-7.
42. Hu MC, Crowe DT, Weissman IL, Holzmann B. Cloning and expression of mouse integrin beta p(beta 7): a functional role in Peyer's patch-specific lymphocyte homing. Proc Natl Acad Sci U S A 1992;89:8254-8.
43. Yu Q, Geng Y, Sicinski P. Specific protection against breast cancers by cyclin D1 ablation. Nature 2001;411:1017-21. (Pubitemid 32612319)
44. Pelosio P, Barbareschi M, Bonoldi E, Marchetti A, Verderio P, Caffo O, et al. Clinical significance of cyclin D1 expression in patients with node-positive breast carcinoma treated with adjuvant therapy. Ann Oncol 1996;7:695-703. (Pubitemid 26323542)
45. Liu B, Park E, Zhu F, Bustos T, Liu J, Shen J, et al. A critical role for I kappaB kinase alpha in the development of human and mouse squamous cell carcinomas. Proc Natl Acad Sci U S A 2006;103:17202-7. (Pubitemid 44788947)
46. Coqueret O. Linking cyclins to transcriptional control. Gene 2002;299:35-55. (Pubitemid 35379826)
47. Gladden AB, Diehl JA. Location, location, location: the role of cyclin D1 nuclear localization in cancer. J Cell Biochem 2005;96:906-13. (Pubitemid 41688717)
48. Lamb J, Ramaswamy S, Ford HL, Contreras B, Martinez RV, Kittrell FS, et al. A mechanism of cyclin D1 action encoded in the patterns of gene expression in human cancer. Cell 2003;114:323-34. (Pubitemid 36962931)
49. Park KJ, Krishnan V, O'Malley BW, Yamamoto Y, Gaynor RB. Formation of an IKKalpha-dependent transcription complex is required for estrogen receptor-mediated gene activation. Mol Cell 2005;18:71-82. (Pubitemid 40444649)
50. Anest V, Cogswell PC, Baldwin AS Jr. A nucleosomal function for IkappaB kinase-alpha in NF-kappaB-dependent gene expression. J Biol Chem 2004;279:31183-9.